Bodal Chemicals Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹709Cr
- +56.2% YoY
- +20.6% QoQ
- Net profit
- ₹30Cr
- +200% YoY
- −6.2% QoQ
- Margin
- 10%
- 0 pp YoY
- −2 pp QoQ
Guidance rank: #34 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Bodal Chemicals Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1 FY27 total revenue: Rs. 7,152 mn, up 56% YoY (from Rs. 4,583 mn Q1 FY26) [Page 6, 5]. Q1 FY27 EBITDA: Rs. 751 million, up 45.4% YoY (from Rs. 516.6 million in Q1 FY26).
From Bodal Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1 FY27 total revenue: Rs. 7,152 mn, up 56% YoY (from Rs. 4,583 mn Q1 FY26) [Page 6, 5]
- Consolidated Q1 FY27 revenue from operations: Rs. 7,090.4 mn vs Rs. 4,542.0 mn Q1 FY26 (+56.1%) [Page 10]
- EBITDA Q1 FY27: Rs. 751 mn, +45% YoY [Pages 5, 6, 10]
- PAT Q1 FY27: Rs. 304 mn, up 218.7% YoY [Page 10]
- Revenue breakup Q1 FY27 vs Q1 FY26 (Consolidated):
- Dye intermediates: Rs. 2,166 mn, +44% YoY
- Dyestuff: Rs. 1,490 mn, +23% YoY
- Basic Chemicals: Rs. 839 mn, +89% YoY
- Chlor Alkali: Rs. 870 mn, +3% YoY [Page 5]
2 more points from Bodal Chemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The presentation mentions a "New greenfield expansion" under the "Way Forward" section (Page 27) as part of growth strategy.
- It also refers to "Capacity rampup" and "Ongoing internal efficiencies" supporting growth (Page 27).
- The Integrated Business Model section (Page 24) notes continuous investment into R&D and well-equipped production facilities, indicating ongoing enhancements.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Bodal Chemicals Ltd — Quarterly revenue & net profit
Bodal Chemicals Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 709 | 454 | +56.2% | 588 | +20.6% |
| Operating profit (EBITDA) | 69 | 48 | +43.8% | 69 | 0% |
| Operating margin | 10% | 10% | 0 pp | 12% | -2 pp |
| Profit before tax | 39 | 13 | +200% | 36 | +8.3% |
| Net profit (PAT) | 30 | 10 | +200% | 32 | -6.2% |
| EPS (₹) | 2.41 | 0.76 | +217.1% | 2.55 | -5.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹863 Cr, net profit ₹81 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bodal Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bodal Chemicals Ltd Q1 FY27 results?
Q1 FY27 total revenue: Rs. 7,152 mn, up 56% YoY (from Rs. 4,583 mn Q1 FY26) [Page 6, 5]. Q1 FY27 EBITDA: Rs. 751 million, up 45.4% YoY (from Rs. 516.6 million in Q1 FY26).
What is Bodal Chemicals Ltd share price analysis?
Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹2,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bodal Chemicals Ltd planning capital expenditure?
The presentation mentions a "New greenfield expansion" under the "Way Forward" section (Page 27) as part of growth strategy.
Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
